Security key
05156V102
Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH)
CUSIP: 05156V102
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Common Shares, no par value
- Shares outstanding
- 132,929,348
- Total 13F shares
- 58,318,900
- Share change
- -3,789,946
- Total reported value
- $494,168,918
- Put/Call ratio
- 65%
- Price per share
- $8.47
- Number of holders
- 216
- Value change
- -$31,810,462
- Number of buys
- 99
- Number of sells
- 89
Report period
Q2 2025
Institutions
216
Top holders
10
AUPH full security history
Newer quarter: Q3 2025
Previous quarter: Q1 2025
Aurinia Pharmaceuticals Inc. SEC filings
Aurinia Pharmaceuticals Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 05156V102
Recent filing periods:
Top shareholders of AUPH - Aurinia Pharmaceuticals Inc. - Common Shares, no par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
7.5%
|
10,029,500
|
$80,637,180 | — | 31 Mar 2025 | |
| BlackRock, Inc. |
13F
|
Company |
6.6%
|
8,759,388
|
$70,425,481 | — | 31 Mar 2025 | |
| ARMISTICE CAPITAL, LLC |
13D/G
13F
|
Company |
4.5%
|
6,400,000
|
$51,840,000 | $0 | 31 Dec 2024 | |
| NEA Management Company, LLC |
13F
|
Company |
3%
|
3,969,834
|
$31,917,465 | — | 31 Mar 2025 | |
| STATE STREET CORP |
13F
|
Company |
2.1%
|
2,851,166
|
$22,923,375 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
1.8%
|
2,367,762
|
$19,036,807 | — | 31 Mar 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.5%
|
1,971,806
|
$15,853,320 | — | 31 Mar 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.3%
|
1,734,300
|
$13,943,705 | — | 31 Mar 2025 | |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP |
13F
|
Company |
1.2%
|
1,640,432
|
$13,189,073 | — | 31 Mar 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1.2%
|
1,631,482
|
$13,117,115 | — | 31 Mar 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.94%
|
1,245,549
|
$10,014,214 | — | 31 Mar 2025 | |
| LAZARD ASSET MANAGEMENT LLC |
13F
|
Company |
0.94%
|
1,245,032
|
$10,010,000 | — | 31 Mar 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.77%
|
1,027,483
|
$8,260,964 | — | 31 Mar 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.71%
|
938,600
|
$7,546,344 | — | 31 Mar 2025 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.64%
|
856,148
|
$6,883,430 | — | 31 Mar 2025 | |
| JUPITER ASSET MANAGEMENT LTD |
13F
|
Company |
0.57%
|
752,769
|
$6,052,263 | — | 31 Mar 2025 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
0.56%
|
746,229
|
$5,999,681 | — | 31 Mar 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.53%
|
701,502
|
$5,640,077 | — | 31 Mar 2025 | |
| Trexquant Investment LP |
13F
|
Company |
0.53%
|
700,638
|
$5,633,130 | — | 31 Mar 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.39%
|
521,416
|
$4,192,185 | — | 31 Mar 2025 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.38%
|
503,543
|
$4,048,485 | — | 31 Mar 2025 | |
| Woodline Partners LP |
13F
|
Company |
0.38%
|
500,416
|
$4,023,345 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.3%
|
397,171
|
$3,193,255 | — | 31 Mar 2025 | |
| Norris Financial Group, LLC |
13F
|
Company |
0.29%
|
387,843
|
$3,118,258 | — | 31 Mar 2025 | |
| SEGALL BRYANT & HAMILL, LLC |
13F
|
Company |
0.28%
|
368,787
|
$2,965,047 | — | 31 Mar 2025 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.28%
|
367,661
|
$2,956,000 | — | 31 Mar 2025 | |
| Michael Robert Martin |
3/4/5
|
Chief Business Officer |
—
class O/S missing
|
259,162
|
$2,918,164 | — | 02 Mar 2023 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.27%
|
353,270
|
$2,840,294 | — | 31 Mar 2025 | |
| NORDEA INVESTMENT MANAGEMENT AB |
13F
|
Company |
0.26%
|
349,600
|
$2,814,280 | — | 31 Mar 2025 | |
| SCHRODER INVESTMENT MANAGEMENT GROUP |
13F
|
Company |
0.24%
|
314,785
|
$2,609,568 | — | 31 Mar 2025 | |
| STATE OF WISCONSIN INVESTMENT BOARD |
13F
|
Company |
0.24%
|
322,750
|
$2,594,910 | — | 31 Mar 2025 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.24%
|
317,656
|
$2,553,954 | — | 31 Mar 2025 | |
| PDT Partners, LLC |
13F
|
Company |
0.24%
|
314,519
|
$2,528,733 | — | 31 Mar 2025 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.24%
|
312,556
|
$2,512,950 | — | 31 Mar 2025 | |
| Scott Michael Habig |
3/4/5
|
Chief Commercial Officer |
—
class O/S missing
|
456,338
|
$2,423,155 | — | 06 Aug 2024 | |
| Marex Group plc |
13F
|
Company |
0.23%
|
300,000
|
$2,412,000 | — | 31 Mar 2025 | |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main |
13F
|
Company |
0.21%
|
285,152
|
$2,292,622 | — | 31 Mar 2025 | |
| IFP Advisors, Inc |
13F
|
Company |
0.21%
|
277,580
|
$2,231,743 | — | 31 Mar 2025 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.2%
|
264,423
|
$2,125,961 | — | 31 Mar 2025 | |
| UBS Group AG |
13F
|
Company |
0.19%
|
257,139
|
$2,067,398 | — | 31 Mar 2025 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.19%
|
252,446
|
$2,029,666 | — | 31 Mar 2025 | |
| Volker Knappertz |
3/4/5
|
EVP, Research and Development |
—
class O/S missing
|
319,128
|
$1,946,681 | — | 27 Feb 2024 | |
| Swiss National Bank |
13F
|
Company |
0.18%
|
235,800
|
$1,895,832 | — | 31 Mar 2025 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.17%
|
229,734
|
$1,847,061 | — | 31 Mar 2025 | |
| RICE HALL JAMES & ASSOCIATES, LLC |
13F
|
Company |
0.17%
|
225,470
|
$1,812,779 | — | 31 Mar 2025 | |
| HUSSMAN STRATEGIC ADVISORS, INC. |
13F
|
Company |
0.16%
|
210,000
|
$1,688,400 | — | 31 Mar 2025 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.15%
|
193,735
|
$1,557,613 | — | 31 Mar 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.13%
|
178,533
|
$1,435,405 | — | 31 Mar 2025 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.12%
|
163,813
|
$1,317,057 | — | 31 Mar 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.12%
|
163,073
|
$1,311,107 | — | 31 Mar 2025 |
Institutional Holders of Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH) as of Q2 2025
As of 30 Jun 2025,
Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH) was held by
216 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
58,318,900 shares.
The largest 10 holders included
TANG CAPITAL MANAGEMENT LLC, BlackRock, Inc., NEA Management Company, LLC, STATE STREET CORP, MORGAN STANLEY, VANGUARD GROUP INC, ARMISTICE CAPITAL, LLC, GEODE CAPITAL MANAGEMENT, LLC, Qube Research & Technologies Ltd, and RENAISSANCE TECHNOLOGIES LLC.
This page lists
218
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
210
Q2 2025 holders
216
Holder diff
6
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.